Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Wallis

Showing results (141-150 of 189) with videos related to

Pageof 19
Sort By:
Southern African Journal of HIV Medicine|December 27, 2021
Corrigendum: Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020Linda-Gail Bekker, Benjamin Brown, Dvora Joseph-Davey, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 20, 2024
Nucleic acid amplification testing using dried blood spots to confirm the diagnosis of HIV-1 in adultsBenjamin A Pinsky, Malaya K Sahoo, Justen Manasa, et al.
AIDS Research and Therapy|January 5, 2023
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistanceRobert A Salata, Beatriz Grinsztejn, Justin Ritz, et al.
The Lancet. HIV|June 1, 2016
Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority studyAlberto M La Rosa, Linda J Harrison, Babafemi Taiwo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 30, 2010
HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral therapy in Lusaka, ZambiaRaph L Hamers, Margaret Siwale, Carole L Wallis, et al.
Infection Control and Hospital Epidemiology|July 10, 2004
Airborne dispersal as a novel transmission route of coagulase-negative staphylococci: interaction between coagulase-negative staphylococci and rhinovirus infectionWerner E Bischoff, Stefano Bassetti, Barbara A Bassetti-Wyss, et al.
Journal of Virological Methods|November 18, 2009
Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1Carole L Wallis, Maria A Papathanasopoulos, Shabir Lakhi, et al.
Frontiers in Environmental Science|December 3, 2020
Challenging Global Waste Management - Bioremediation to Detoxify AsbestosShannon L Wallis, Edward A Emmett, Robyn Hardy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2013
HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomesRaph L Hamers, Hans L Zaaijer, Carole L Wallis, et al.
The Lancet. Digital Health|September 19, 2019
Two-way mobile phone intervention compared with standard-of-care adherence support after second-line antiretroviral therapy failure: a multinational, randomised controlled trialRobert Gross, Justin Ritz, Michael D Hughes, et al.
Pageof 19

Showing results (141-150 of 189) with videos related to

Sort By:
Pageof 19
Southern African Journal of HIV Medicine|December 27, 2021
Corrigendum: Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020Linda-Gail Bekker, Benjamin Brown, Dvora Joseph-Davey, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 20, 2024
Nucleic acid amplification testing using dried blood spots to confirm the diagnosis of HIV-1 in adultsBenjamin A Pinsky, Malaya K Sahoo, Justen Manasa, et al.
AIDS Research and Therapy|January 5, 2023
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistanceRobert A Salata, Beatriz Grinsztejn, Justin Ritz, et al.
The Lancet. HIV|June 1, 2016
Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority studyAlberto M La Rosa, Linda J Harrison, Babafemi Taiwo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 30, 2010
HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral therapy in Lusaka, ZambiaRaph L Hamers, Margaret Siwale, Carole L Wallis, et al.
Infection Control and Hospital Epidemiology|July 10, 2004
Airborne dispersal as a novel transmission route of coagulase-negative staphylococci: interaction between coagulase-negative staphylococci and rhinovirus infectionWerner E Bischoff, Stefano Bassetti, Barbara A Bassetti-Wyss, et al.
Journal of Virological Methods|November 18, 2009
Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1Carole L Wallis, Maria A Papathanasopoulos, Shabir Lakhi, et al.
Frontiers in Environmental Science|December 3, 2020
Challenging Global Waste Management - Bioremediation to Detoxify AsbestosShannon L Wallis, Edward A Emmett, Robyn Hardy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2013
HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomesRaph L Hamers, Hans L Zaaijer, Carole L Wallis, et al.
The Lancet. Digital Health|September 19, 2019
Two-way mobile phone intervention compared with standard-of-care adherence support after second-line antiretroviral therapy failure: a multinational, randomised controlled trialRobert Gross, Justin Ritz, Michael D Hughes, et al.
Pageof 19